Future threats from coronaviruses – The Lancet Respiratory Medicine

Coronaviruses are RNA viruses that infect a wide range of mammalian and avian species, and many are capable of transmitting between species. CoV-229E and OC43 coronaviruses jumped from bats to…

Dangerous Medicine – The Lancet Gastroenterology & Hepatology

It is impossible to know how many people were deliberately infected with the hepatitis A and B viruses by American researchers in the mid-20th century. Sydney Halpern, the author of…

Bayer Pronounces Publication of Part IV Adempas® (riociguat) Knowledge in The Lancet Respiratory Medication

WHIPPANY, N.J.–(BUSINESS WIRE)– Bayer today announced that The Lancet Respiratory Medicine has published results from the Phase IV REPLACE (Riociguat rEplacing PDE-5i therapy evaLuated Against Continued PDE-5i thErapy) study in which…

Bayer Declares Publication of Section IV Adempas® (riociguat) Information in The Lancet Respiratory Medication

WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer today announced that The Lancet Respiratory Medicine has published results from the Phase IV REPLACE (Riociguat rEplacing PDE-5i therapy evaLuated Against Continued PDE-5i thErapy) study in which…